Logo CICANCER

Old CIC Events

Targeting RAS: New Avenues and Challenges 08/10/2025

Targeting RAS: New Avenues and Challenges

Symposium — https://targetingras.com/

Linking metabolism and anti-cancer functions of dendritic cells 02/10/2025

Linking metabolism and anti-cancer functions of dendritic cells

Stefanie K. Wculek — IRB and BIST, Barcelona

Defensa de tesis: Preclinical and Clinical Evaluation of Belantamab Mafodotin Based Immunotherapy Combinations in Multiple Myeloma 26/09/2025

Defensa de tesis: Preclinical and Clinical Evaluation of Belantamab Mafodotin Based Immunotherapy Combinations in Multiple Myeloma

Mauro Lorenzo Mohamed — Programa de doctorado de biociencias: biología y clínica de cáncer

Impact of METTL1 in Glioblastoma development and intratumoral immune response 25/09/2025

Impact of METTL1 in Glioblastoma development and intratumoral immune response

Aurora Campos — Centro de Investigación del Cáncer (Universidad de Salamanca-CSIC)

Unlocking Bioinformatics: Interactive Tools for Visual and Web-Based Analysis 18/09/2025

Unlocking Bioinformatics: Interactive Tools for Visual and Web-Based Analysis

Carlos Prieto — Nucleus Universidad de Salamanca

Defensa de la tesis doctoral: Functional Analysis of PCNA Deubiquitylation in Replication Fork Dynamics and Okazaki Fragment Maturation in Saccharomyces cerevisiae 18/07/2025

Defensa de la tesis doctoral: Functional Analysis of PCNA Deubiquitylation in Replication Fork Dynamics and Okazaki Fragment Maturation in Saccharomyces cerevisiae

Javier Zamarreño Lozano — Programa de doctorado de biociencias: biología y clínica de cáncer

Precision Biology for Precision Medicine: Cancer Genomics in Hematological Malignancies 17/07/2025

Precision Biology for Precision Medicine: Cancer Genomics in Hematological Malignancies

Xosé S. Puente — IUOPA-Universidad de Oviedo

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress. 14/07/2025

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress.

Cristian Prieto — IBCII - Univ. Frankfurt

RAS-PI3K signalling regulates myCAF phenotype acquisition to modulate tumour progression 10/07/2025

RAS-PI3K signalling regulates myCAF phenotype acquisition to modulate tumour progression

Marta Alcón — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies 07/07/2025

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies

Juan José Montero Valderrama — Institute of Molecular Oncology and Functional Genomics (IMO), Technical University of Munich (TUM). Munich

The long journey to develop a drug against an “undruggable” target in cancer 03/07/2025

The long journey to develop a drug against an “undruggable” target in cancer

Laura Soucek — Vall d´Hebron, Barcelona